Genetics tools for highly pathogenic Francisella tularensis subsp. tularensis

Microbiology

Volumn 152, Issue 11, 2006, Pages 3425-3435

  LoVullo, Eric D ^a   Sherrill, Lani A ^a   Perez, Lanyn L ^a,b   Pavelka Jr , Martin S ^a  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b UNIVERSITY OF MARYLAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; BACTERIAL PROTEIN; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE; HYGROMYCIN; KANAMYCIN; LIVE VACCINE; PROTEIN BLAA; PROTEIN BLAB; PROTEIN HYG; UNCLASSIFIED DRUG; CINNAMIC ACID DERIVATIVE; DRUG DERIVATIVE; HYGROMYCIN B;

ALLELE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GENETICS; BACTERIAL STRAIN; CONTROLLED STUDY; ELECTROPORATION; FRANCISELLA TULARENSIS; GENE DELETION; GENE MUTATION; GENETIC MARKER; MUTAGENESIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PATHOGENICITY; PHENOTYPE; PLASMID; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; TRANSPOSON; BACTERIAL GENE; DRUG EFFECT; ESCHERICHIA COLI; GENE VECTOR; GENETICS;

FRANCISELLA TULARENSIS; FRANCISELLA TULARENSIS SUBSP. TULARENSIS;

AMPICILLIN; BETA-LACTAM RESISTANCE; BETA-LACTAMASES; CINNAMATES; DRUG RESISTANCE, BACTERIAL; ESCHERICHIA COLI; FRANCISELLA TULARENSIS; GENES, BACTERIAL; GENETIC MARKERS; GENETIC VECTORS; HYGROMYCIN B; KANAMYCIN; PLASMIDS; PROMOTER REGIONS (GENETICS);

EID: 33750934728     PISSN: 13500872     EISSN: None     Source Type: Journal    
DOI: 10.1099/mic.0.29121-0     Document Type: Article

References (33)

1. Ausubel, F. M., Brent, R., Kingston, R. E., Moore, D. D., Seidman, J. G., Smith, J. A. & Struhl, K. (1987). Current Protocols in Molecular Biology. New York: Greene Publishing Associates and Wiley-Interscience.
2. Baker, C. N., Hollis, D. G. & Thomsberry, C. (1985). Antimicrobial susceptibility testing of Francisella tularensis with a modified Mueller-Hinton broth. J Clin Microbiol 22, 212-215.
3. Cowley, S. C., Gray, C. J. & Nano, F. E. (2000). Isolation and characterization of Francisella novicida mutants defective in lipopolysaccharide biosynthesis. FEMS Microbiol Lett 182, 63-67.
4. Dennis, D. T., Inglesby, T. V., Henderson, D. A. & 15 other authors (2001). Tularemia as a biological weapon: medical and public health management. JAMA 285, 2763-2773.
5. Derbyshire, K. M., Takacs, C. & Huang, J. (2000). Using the EZ:: TN transposome for transposon mutagenesis in Mycobacterium smegmatis. Epicentre Forum 7, 1-4.
6. Eigelsbach, H. T. & Downs, C. M. (1961). Prophylactic effectiveness of live and killed tularemia vaccines. I. Production of vaccine and evaluation in the white mouse and guinea pig. J Immunol 87, 415-425.
7. Ericsson, M., Golovliov, I., Sandstrom, G., Tarnvik, A. & Sjostedt, A. (1997). Characterization of the nucleotide sequence of the groE operon encoding heat shock proteins chaperone-60 and -10 of Francisella tularensis and determination of the T-cell response to the proteins in individuals vaccinated with F. tularensis. Infect Immun 65, 1824-1829.
8. Flores, A. R., Parsons, L. M. & Pavelka, M. S., Jr (2005a). Characterization of novel Mycobacterium tuberculosis and Mycobacterium, smegmatis mutants hypersusceptible to beta-lactam antibiotics. J Bacteriol 187, 1892-1900.
9. Flores, A. R., Parsons, L. M. & Pavelka, M. S., Jr (2005b). Genetic analysis of the beta-lactamases of Mycobacterium tuberculosis and Mycobacterium smegmatis and susceptibility to beta-lactam antibiotics. Microbiology 151, 521-532.
10. Garcia Del Blanco, N., Dobson, M. E., Vela, A. I. & 7 other authors (2002). Genotyping of Francisella tularensis strains by pulsed-field gel electrophoresis, amplified fragment length polymorphism fingerprinting, and 16S rRNA gene sequencing. J Clin Microbiol 40, 2964-2972.
11. Gerdes, K., Christensen, S. K. & Lobner-Olesen, A. (2005). Prokaryotic toxin-antitoxin stress response loci. Nat Rev Microbiol 3, 371-382.
12. Golovliov, I., Sjostedt A., Mokrievich, A. & Pavlov, V. (2003). A method for allelic replacement in Francisella tularensis. FEMS Microbiol Lett 222, 273-280.
13. Goryshin, I. Y., Jendrisak, J, Hoffman, L. M., Meis, R. & Reznikoff, W. S. (2000). Insertional transposon mutagenesis by electroporation of released Tn5 transposition complexes. Nat Biotechnol 18, 97-100.
14. Hollis, D. G., Weaver, R. E., Steigerwalt, A. G., Wenger, J. D., Moss, C. W. & Brenner, D. J. (1989). Francisella philomiragia comb. nov. (formerly Yersinia philomiragia) and Francisella tularensis biogroup novicida (formerly Francisella novicida) associated with human disease. J Clin Microbiol 27, 1601-1608.
15. Johansson, A., Goransson, I., Larsson, P. & Sjostedt, A. (2001). Extensive allelic variation among Francisella tularensis strains in a short-sequence tandem repeat region. J Clin Microbiol 39, 3140-3146.
16. Johansson, A., Farlow, J., Larsson, P. & 8 other authors (2004). Worldwide genetic relationships among Francisella tularensis isolates determined by multiple-locus variable-number tandem repeat analysis. J Bacteriol 186, 5808-5818.
17. Kawula, T. H., Hall, J. D., Fuller, J. R. & Craven, R. R. (2004). Use of transposon-transposase complexes to create stable insertion mutant strains of Francisella tularensis LVS. Appl Environ Microbiol 70, 6901-6904.
18. Lauriano, C. M., Barker, J. R., Nano, F. E., Arulanandam, B. P. & Klose, K. E. (2003). Allelic exchange in Francisella tularensis using PCR products. FEMS Microbiol Lett 229, 195-202.
19. Leboul, J. & Davies, J. (1982). Enzymatic modification of hygromycin B in Streptomyces hygroscopicus. J Antibiot 35, 527-528.
20. Maier, T. M., Havig, A., Casey, M., Nano, F. E., Frank D. W. & Zahrt, T. C. (2004). Construction and characterization of a highly efficient Francisella shuttle plasmid. Appl Environ Microbiol 70, 7511-7519.
21. Maier, T. M., Pechous, R., Casey, M., Zahrt, T. C. & Frank D. W. (2006). In vivo Himar1-based transposon mutagenesis of Francisella tularensis. Appl Environ Microbiol 72, 1878-1885.
22. Malpartida, F., Zalacain, M., Jimenez, A. & Davies, J. (1983). Molecular cloning and expression in Streptomyces lividans of a hygromycin B phosphotransferase gene from Streptomyces hygroscopicus. Biochem Biophys Res Commun 117, 6-12.
23. Nano, F. E., Zhang, N., Cowley, S. C. & 8 other authors (2004). A Francisella tularensis pathogenicity island required for intramacrophage growth. J Bacteriol 186, 6430-6436.
24. Norqvist, A., Kuoppa, K. & Sandstrom, G. (1996). Construction of a shuttle vector for use in Francisella tularensis. FEMS Immunol Med Microbiol 13, 257-260.
25. Pavelka, M. S., Jr & Jacobs, W. R., Jr (1999). Comparison of the construction of unmarked deletion mutations in Mycobacterium smegmatis, Mycobacterium bovis bacillus Calmette-Guerin, and Mycobacterium tuberculosis H37Rv by allelic exchange. J Bacteriol 181, 4780-4789.
26. Pavlov, V. M., Mokrievich, A. N. & Volkovoy, K. (1996). Cryptic plasmid pFNL10 from Francisella novicida-like F6168: the base of plasmid vectors for Francisella tularensis. FEMS Immunol Med Microbiol 13, 253-256.
27. Pomerantsev, A. P., Golovilov, I. R., Ohara, Y., Mokrievich, A. N., Obuchi, M., Norqvist, A., Kuoppa, K. & Pavlov, V. M. (2001a). Genetic organization of the Francisella plasmid pFNLIO. Plasmid 46, 210-222.
28. Pomerantsev, A. P., Obuchi, M. & Ohara, Y. (2001b). Nucleotide sequence, structural organization, and functional characterization of the small recombinant plasmid pOM1 that is specific for Francisella tularensis. Plasmid 46, 86-94.
29. Shaw, K. J., Rather, P. N., Hare, R. S. & Miller, G. H. (1993). Molecular genetics of aminoglycoside resistance genes and familial relationships of the aminoglycoside-modifying enzymes. Microbiol Rev 57, 138-163.
30. Sjostedt, A., Tamvik, A. & Sandstrom, G. (1996). Francisella tularensis: host-parasite interaction. FEMS Immunol Med Microbiol 13, 181-184.
31. Stover, C. K., de la Cruz, V. F., Fuerst, T. R. & 28 other authors (1991). New use of BCG for recombinant vaccines. Nature 351, 456-460.
32. Titball, R. W., Johansson, A. & Forsman, M. (2003). Will the enigma of Francisella tularensis virulence soon be solved? Trends Microbiol 11, 118-123.
33. Twine, S., Bystrom, M., Chen, W. & 9 other authors (2005). A mutant of Francisella tularensis strain SCHU S4 lacking the ability to express a 58-kilodalton protein is attenuated for virulence and is an effective live vaccine. Infect Immun 73, 8345-8352.